成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> ACS Applied Nano Materials >>article
ACS Applied Nano Materials

ACS Applied Nano Materials

IF: 5.29
Download PDF

Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.

Published:25 June 2014 DOI: 10.2147/IJN.S63535 PMID: 25028549
Ruma Maji, Niladri Shekhar Dey, Bhabani Sankar Satapathy, Biswajit Mukherjee, Subhasish Mondal

Abstract

Background: Four formulations of Tamoxifen citrate loaded polylactide-co-glycolide (PLGA) based nanoparticles (TNPs) were developed and characterized. Their internalization by Michigan Cancer Foundation-7 (MCF-7) breast cancer cells was also investigated.

Methods: Nanoparticles were prepared by a multiple emulsion solvent evaporation method. Then the following studies were carried out: drug-excipients interaction using Fourier transform infrared spectroscopy (FTIR), surface morphology by field emission scanning electron microscopy (FESEM), zeta potential and size distribution using a Zetasizer Nano ZS90 and particle size analyzer, and in vitro drug release. In vitro cellular uptake of nanoparticles was assessed by confocal microscopy and their cell viability (%) was studied.

Results: No chemical interaction was observed between the drug and the selected excipients. TNPs had a smooth surface, and a nanosize range (250-380 nm) with a negative surface charge. Drug loadings of the prepared particles were 1.5%±0.02% weight/weight (w/w), 2.68%±0.5% w/w, 4.09%±0.2% w/w, 27.16%±2.08% w/w for NP1-NP4, respectively. A sustained drug release pattern from the nanoparticles was observed for the entire period of study, ie, up to 60 days. Further, nanoparticles were internalized well by the MCF-7 breast cancer cells on a concentration dependent manner and were present in the cytoplasm. The nucleus was free from nanoparticle entry. Drug loaded nanoparticles were found to be more cytotoxic than the free drug.

Conclusion: TNPs (NP4) showed the highest drug loading, released the drug in a sustained manner for a prolonged period of time and were taken up well by the MCF-7 breast cancer cell line in vitro. Thus the formulation may be suitable for breast cancer treatment due to the good permeation of the formulation into the breast cancer cells.

Substances (3)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Tamoxifen citrate 54965-24-1 C32H37NO8 448 suppliers $44.00-$1548.26
PLGA 23 suppliers Inquiry
Poly(lactide-co-glycolide) 2 suppliers Inquiry

Similar articles

IF:10

Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer

Advanced Healthcare Materials Jiali Gong, Danling Cheng,etc Published: 21 November 2024
IF:5.3

Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization

International Journal of Pharmaceutics Yosra S.R. Elnaggar, Magda A. El-Massik,etc Published: 1 October 2009
IF:3

Nanoparticles generated from a tryptophan derivative: physical characterization and anti-cancer drug delivery

Amino Acids Taru Dube, Saurabh Mandal,etc Published: 10 March 2017